TALPHERA, INC. Preferred Stock, Shares Outstanding
TALPHERA, INC. (TLPH) had Preferred Stock, Shares Outstanding of 0 shares as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-03-23
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2023-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2011-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-23 |
| 2024-12-31 | 0.00 shares 10-K · filed 2025-03-31 |
| 2023-12-31 | 0.00 shares 10-K · filed 2024-03-06 |
| 2011-12-31 | 0.00 shares 10-K · filed 2012-03-23 |
| 2011-09-30 | 0.00 shares 10-Q · filed 2011-11-08 |
| 2011-06-30 | 0.00 shares 10-Q · filed 2011-08-11 |
| 2010-12-31 | 7.15M shares 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |